Quarterly report · Q3

Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
MetricValuePeriodScopeSource row
Revenue¥3.41T2022-04-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥1.14T2022-10-01 → 2022-12-31dCons.Revenue IFRS
Revenue¥3.98T2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥2.90T2021-04-01 → 2021-12-31Cons.Revenue IFRS
Revenue¥1.02T2021-10-01 → 2021-12-31dCons.Revenue IFRS
Operating income¥48.6bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income−¥69.7bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Operating income¥218.2bn2021-04-01 → 2021-12-31Cons.Operating profit loss IFRS
Operating income¥65.1bn2021-10-01 → 2021-12-31dCons.Operating profit loss IFRS
Profit before tax¥39.2bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax−¥82.8bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Profit before tax¥290.4bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥208.2bn2021-04-01 → 2021-12-31Cons.Profit loss before tax IFRS
Profit before tax¥61.0bn2021-10-01 → 2021-12-31dCons.Profit loss before tax IFRS
Net income (owners)¥17.0bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥56.9bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥177.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥122.1bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥37.0bn2021-10-01 → 2021-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income¥44.8bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income−¥46.7bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Net income¥209.4bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥147.3bn2021-04-01 → 2021-12-31Cons.Profit loss IFRS
Net income¥45.3bn2021-10-01 → 2021-12-31dCons.Profit loss IFRS
Total assets¥5.86Tat 2022-12-31Cons.Assets IFRS
Total assets¥5.57Tat 2022-03-31Cons.Assets IFRS
Total assets¥5.46Tat 2021-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥3.96Tat 2022-12-31Cons.Liabilities IFRS
Total liabilities¥3.73Tat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥1.90Tat 2022-12-31Cons.Equity IFRS
Net assets / equity¥1.84Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥1.71Tat 2021-12-31Cons.Equity IFRS
Net assets / equity¥1.57Tat 2021-03-31dCons.Equity IFRS
Equity (owners)¥1.50Tat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.46Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.35Tat 2021-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥257.0bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥245.8bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥259.3bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥349.6bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥174.0bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥346.9bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥248.0bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥174.4bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥128.8bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥140.6bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥8.8bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥336.3bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥200.6bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥11.992022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥-40.022022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥124.682021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥85.952021-04-01 → 2021-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥26.012021-10-01 → 2021-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥11.552022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-40.022022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥115.032021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥79.062021-04-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥23.932021-10-01 → 2021-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio25.5%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio26.2%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.7%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥309.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥162.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥147.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥11.4bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥230.7bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥230.7bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥9.7bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue2022-04-01 → 2022-12-31¥1.14T
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.10T
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥37.2bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentsegment profit2022-04-01 → 2022-12-31¥19.3bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue2022-04-01 → 2022-12-31¥332.0bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue external2022-04-01 → 2022-12-31¥331.6bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥416m
jpcrp040300-q3r_E00808-000Health Carereportable segmentsegment profit2022-04-01 → 2022-12-31¥18.5bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue2022-04-01 → 2022-12-31¥873.0bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue external2022-04-01 → 2022-12-31¥866.4bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥6.7bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentsegment profit2022-04-01 → 2022-12-31¥84.3bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥983.5bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥944.5bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥38.9bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥54.1bn
—segment totalrevenue2022-04-01 → 2022-12-31¥3.33T
—segment totalrevenue external2022-04-01 → 2022-12-31¥3.24T
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥83.2bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥176.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥3.64T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥3.41T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥230.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥187.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-12-31¥279.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-12-31¥130.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-12-31¥148.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-12-31¥10.3bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥223.8bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥223.8bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥10.8bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue2021-04-01 → 2021-12-31¥953.7bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue external2021-04-01 → 2021-12-31¥921.8bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥31.9bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentsegment profit2021-04-01 → 2021-12-31¥83.5bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue2021-04-01 → 2021-12-31¥312.4bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue external2021-04-01 → 2021-12-31¥312.1bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥247m
jpcrp040300-q3r_E00808-000Health Carereportable segmentsegment profit2021-04-01 → 2021-12-31¥4.6bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue2021-04-01 → 2021-12-31¥691.5bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue external2021-04-01 → 2021-12-31¥686.6bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥5.0bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentsegment profit2021-04-01 → 2021-12-31¥73.9bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue2021-04-01 → 2021-12-31¥887.4bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue external2021-04-01 → 2021-12-31¥848.9bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥38.5bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentsegment profit2021-04-01 → 2021-12-31¥57.5bn
—segment totalrevenue2021-04-01 → 2021-12-31¥2.84T
—segment totalrevenue external2021-04-01 → 2021-12-31¥2.77T
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥75.6bn
—segment totalsegment profit2021-04-01 → 2021-12-31¥219.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥3.12T
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥2.90T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥223.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥229.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 925
ItemContextValueUnit
Profit loss before tax IFRSPrior1QuarterDuration61012000000JPY
Profit loss before tax IFRSCurrentQuarterDuration-82760000000JPY
Income tax expense IFRSPrior1QuarterDuration15688000000JPY
Income tax expense IFRSCurrentQuarterDuration-36038000000JPY
Profit loss IFRSPrior1QuarterDuration45324000000JPY
Profit loss IFRSCurrentQuarterDuration-46722000000JPY
Profit loss attributable to owners of parent IFRSPrior1QuarterDuration36966000000JPY
Profit loss attributable to owners of parent IFRSCurrentQuarterDuration-56905000000JPY
Profit loss attributable to non controlling interests IFRSPrior1QuarterDuration8358000000JPY
Profit loss attributable to non controlling interests IFRSCurrentQuarterDuration10183000000JPY
Basic earnings loss per share IFRSPrior1QuarterDuration26.01
Basic earnings loss per share IFRSCurrentQuarterDuration-40.02
Diluted earnings loss per share IFRSPrior1QuarterDuration23.93
Diluted earnings loss per share IFRSCurrentQuarterDuration-40.02
Profit loss IFRSPrior1YTDDuration147259000000JPY
Profit loss IFRSCurrentYTDDuration44806000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration7449000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration7169000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration7528000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration-4039000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration-84000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration445000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration14893000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration3575000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration27847000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration60217000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration-355000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration2594000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration1689000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration10276000000JPY
Total of items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration29181000000JPY
Total of items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration73087000000JPY
Other comprehensive income IFRSPrior1YTDDuration44074000000JPY
Other comprehensive income IFRSCurrentYTDDuration76662000000JPY
Comprehensive income IFRSPrior1YTDDuration191333000000JPY
Comprehensive income IFRSCurrentYTDDuration121468000000JPY
Comprehensive income attributable to owners of parent IFRSPrior1YTDDuration156259000000JPY
Comprehensive income attributable to owners of parent IFRSCurrentYTDDuration81936000000JPY
Comprehensive income attributable to non controlling interests IFRSPrior1YTDDuration35074000000JPY
Comprehensive income attributable to non controlling interests IFRSCurrentYTDDuration39532000000JPY
Profit loss IFRSPrior1QuarterDuration45324000000JPY
Profit loss IFRSCurrentQuarterDuration-46722000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1QuarterDuration-5182000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentQuarterDuration-5086000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSPrior1QuarterDuration1130000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSCurrentQuarterDuration-1140000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that will not be reclassified to profit or loss oci IFRSPrior1QuarterDuration63000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that will not be reclassified to profit or loss oci IFRSCurrentQuarterDuration377000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSPrior1QuarterDuration-3989000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSCurrentQuarterDuration-5849000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2021-10-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass